HESI Practice Test Pharmacology Related

Review HESI Practice Test Pharmacology related questions and content

A client diagnosed with multiple sclerosis self-administers beta-1 interferon subcutaneously

  • A. Explain to the client that the medication dose may need to be increased
  • B. Instruct the client to withhold the drug until the next exacerbation
  • C. Advise the client to consult the healthcare provider as soon as possible
  • D. Encourage the client to continue taking the medication
Correct Answer: D

Rationale: Encouraging the client to continue taking the medication is crucial in the management of multiple sclerosis. Beta-1 interferon is a disease-modifying drug used to reduce the frequency and severity of relapses in multiple sclerosis. Discontinuing the medication without medical advice can lead to disease exacerbation. It is essential for the client to maintain regular dosing to achieve optimal therapeutic effects and disease control.